C44.511
Basal cell carcinoma of skin of breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Basal cell carcinoma of the skin of the breast is a type of skin cancer that originates from the basal cells, which are found in the deepest layer of the epidermis. Though it most commonly appears in sun-exposed areas like the face and neck, it can also develop on the skin of the breast. This form of skin cancer is typically slow-growing and unlikely to metastasize, making early detection and treatment very effective. Understanding this condition can help patients recognize symptoms and seek appropriate care.
Causes & Symptoms
Clinical Causes: Chronic exposure to ultraviolet (UV) radiation from the sun or tanning beds Repeated skin injuries or irritation in the affected area Fair skin that burns easily and does not tan well Older age, as risk increases over time A history of skin cancer or other skin conditions Genetic factors that increase susceptibility
Key Symptoms: A shiny, pearly bump with or without visible blood vessels A flat, firm, scaly lesion that may resemble a scar or ulcer A sore that doesn’t heal or keeps recurring A new growth or a change in an existing mole or lesion on the breast Widening of the surface or bleeding from the lesion
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough physical examination by a healthcare provider, focusing on skin lesions. A dermatologist may perform a biopsy—removing a small sample of tissue from the lesion—for laboratory analysis. This confirms whether the lesion is basal cell carcinoma and helps determine its characteristics. Additional imaging tests are typically not necessary unless there is concern for deeper tissue involvement, which is rare in basal cell carcinoma of the skin of the breast.
Treatment Protocols: Surgical excision to remove the cancerous tissue completely Mohs micrographic surgery, especially for lesions in cosmetically or functionally critical areas Cryotherapy, which involves freezing the lesion with liquid nitrogen Topical medications for superficial lesions, such as imiquimod or 5-fluorouracil Photodynamic therapy in select cases Radiation therapy, generally reserved for cases where surgery isn’t suitable or complete removal is challenging
Clinical Advice & FAQs
Billing Guidance
Is C44.511 a billable ICD-10 code?
Yes, C44.511 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C44.511?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference